[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520116":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":24,"responsibleParty":45,"collaborators":18,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":18,"enrollmentInfo":57,"targetDuration":18,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":18,"overallStatus":26,"whyStopped":18,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Centre Hospitalier Emile Roux","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Reinforced sleep program","EXPERIMENTAL","standard pain management + sleep disorders management",[13],"Other: Standard pain management combined with sleep disorder management",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard care","NO_INTERVENTION","Control group: standard pain management",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Standard pain management combined with sleep disorder management","Standard pain management combined with sleep disorder management at M6, and M12",[9],[25],{"facility":5,"status":26,"city":27,"state":18,"zip":18,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Le Puy-en-Velay","France","FR",{"type":31,"coordinates":32},"Point",[33,34],3.88523,45.04366,{"lat":34,"lon":33},[37,42],{"name":38,"role":39,"phone":40,"phoneExt":18,"email":41},"Sophie LENGAGNE","CONTACT","0471043526","sophie.lengagne@ch-lepuy.fr",{"name":43,"role":44,"phone":18,"phoneExt":18,"email":18},"Christèle PEREZ, MD","PRINCIPAL_INVESTIGATOR",{"type":46,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100520116","optimization-of-the-care-pathway-for-patients-with-chronic-pain-assessing-the-value-of-integrating-sleep-specialists-100520116",false,"NCT06052384","Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists","Optimisation du Parcours de Soins Des Patients Atteints de Douleurs Chroniques : étude randomisée évaluant l'intérêt de l'intégration Des spécialistes du Sommeil","DOLOREPIT","Inclusion Criteria:\n\n* First consultation at the pain management center\n* Patient with chronic pain as defined by the \"Haute Autorité de Santé\". The pain must have several of the following characteristics:\n\n  * Persistence or recurrence\n  * Duration beyond what is usual for the presumed initial cause, especially if the pain has been evolving for more than 3 months;\n  * Inadequate response to treatment;\n  * Important and progressive deterioration of the patient's functional and interpersonal abilities in activities of daily living at home, school, or work due to the pain.\n* Patients with chronic primary pain (according to the typology defined by the International Classification of Diseases-11) and classified into one of the 4 following categories:\n\n  * Chronic generalized pain\n  * Complex regional pain syndrome\n  * Chronic primary headache or orofacial pain\n  * Chronic primary musculoskeletal pain\n* Pittsburgh Sleep Quality Index (PSQI) must be completed by the patient and the score must be available (for randomization purposes)\n* Have access to an internet connection as a self-administered questionnaire is to complete online, and at least have access to the online platform for CBT treatment if insomnia is detected\n* Affiliation to a French social security system\n* Free informed consent\n\nExclusion Criteria:\n\n* Patients undergoing cancer treatment or who have completed treatment within the last 2 years\n* Patient with a chronic inflammatory disease (e.g. rheumatoid arthritis, ankylosing spondylitis, chronic inflammatory bowel disease, Horton's disease, Wegener's disease, myositis, Still's disease, lupus erythematosus, etc.)\n* Immunocompromised patient\n* Patient with severe psychiatric pathology that does not allow study follow-up (at the discretion of the investigator)\n* Patient already treated for a sleep disorder by a sleep specialist (the only prescription of hypnotics is not considered as a criterion of non-inclusion)\n* Patient follow-up difficult (for geographic motives or other reasons)\n* Patient under judicial protection of incapable adults or guardianship\n* Refusal to participate in the research","ALL","18 Years",{"count":58,"type":59},664,"ESTIMATED","INTERVENTIONAL",[62],"NA","DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.",[65],"Chronic Pain","2025-07-28",{"date":68,"type":69},"2025-07-30","ACTUAL",{"date":71,"type":69},"2023-12-07",{"date":73,"type":59},"2027-06",{"name":5,"class":6},1]